Prenoxdiazine

Prenoxdiazine
Clinical data
Trade names	Libexin
AHFS/Drugs.com	International Drug Names
ATC code	R05DB18 (WHO) ;
Identifiers
	IUPAC name 1-[2-[3-(2,2-diphenylethyl)-1,2,4-oxadiazol-5-yl]ethyl]piperidine;
CAS Number	982-43-4 ;
PubChem CID	120508;
ChemSpider	107586 ;
UNII	S491HH391H;
CompTox Dashboard (EPA)	DTXSID10197192 ;
Chemical and physical data
Formula	C23H27N3O
Molar mass	361.48 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES n1c(onc1CC(c2ccccc2)c3ccccc3)CCN4CCCCC4;
	InChI InChI=1S/C23H27N3O/c1-4-10-19(11-5-1)21(20-12-6-2-7-13-20)18-22-24-23(27-25-22)14-17-26-15-8-3-9-16-26/h1-2,4-7,10-13,21H,3,8-9,14-18H2 ; Key:PXZDWASDNFWKSD-UHFFFAOYSA-N ;
(verify)

Prenoxdiazine (marketed as Libexin) is a cough suppressant.[1] It acts peripherally by desensitizing the pulmonary stretch receptors. Therefore, there's a reduction of cough impulses originating in the lungs. Prenoxdiazine is indicated in cough of bronchial origin.

References

Csürös, L. (1989). "Fifteen years of experience on the use of Libexin tablets". Therapia Hungarica (English edition). 37 (1): 50–54. PMID 2667194.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Csürös, L. (1989). "Fifteen years of experience on the use of Libexin tablets". Therapia Hungarica (English edition). 37 (1): 50–54. PMID 2667194.